During the past decade, Anxiety and Mood Disorder Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Anxiety and Mood Disorder Center" are "Major Depressive Disorder" (3 trials), "Anxiety" (1 trials) and "Binge Eating Disorder" (1 trials). Many other conditions were trialed in "Anxiety and Mood Disorder Center" in a lesser frequency.

Most popular intervention types in "Anxiety and Mood Disorder Center" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "BCI-540" (1 trials), "Lisdexamfetamine dimesylate" (1 trials), "SPD489 (Lisdexamfetamine dimesylate )" (1 trials) and "SPD489 (Lisdexamfetamine dimesylate) + Antidepressant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Anxiety and Mood Disorder Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Anxiety and Mood Disorder Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Anxiety and Mood Disorder Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Anxiety and Mood Disorder Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".